https://m2.mtmt.hu/ eng 2026-05-31 12:02 JournalArticle 34450917 VALIDATED true Export Date: 20 March 2024 Correspondence Address: Molnár, A.Á.; Heart and Vascular Center, Hungary; email: molnarandreaagnes@gmail.com 0 false 2026-05-23T11:07:42.443+0000 2024-01-12T07:36:24.531+0000 2023-12-27T13:13:29.441+0000 true 10055096 Nagy Regina /api/admin/10055096 Admin Regina Nagy (SE_AOK_Városmajor_Kardiol_Szívseb_Admin5_NR, admin) true 10055096 2025-10-21T06:41:30.389+0000 2024-01-08T12:43:17.486+0000 true 10080205 Szalóky-Siki Ágnes /api/admin/10080205 Admin Ágnes Szalóky-Siki (SE_KK_Admin5_SZSA, admin) true true false true 24 24 /api/publicationtype/24 PublicationType Journal Article 1 true 24 JournalArticle true 1134514 Survey paper true 24 24 /api/publicationtype/24 PublicationType Journal Article 1 true 24 JournalArticle /api/subtype/1134514 Összefoglaló cikk SubType Survey paper (Journal Article) 102 true 1134514 true 1 /api/category/1 Category Scientific true 1 Molnár, Andrea Ágnes true true /api/journal/10003252 REVIEWED INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 true false 10003252 false 10003252 true 1661-6596 1422-0067 Journal FOREIGN 24 24 17129 17129 23 2023 Aging is a major risk factor of atherosclerosis through different complex pathways including replicative cellular senescence and age-related clonal hematopoiesis. In addition to aging, extracellular stress factors, such as mechanical and oxidative stress, can induce cellular senescence, defined as premature cellular senescence. Senescent cells can accumulate within atherosclerotic plaques over time and contribute to plaque instability. This review summarizes the role of cellular senescence in the complex pathophysiology of atherosclerosis and highlights the most important senotherapeutics tested in cardiovascular studies targeting senescence. Continued bench-to-bedside research in cellular senescence might allow the future implementation of new effective anti-atherosclerotic preventive and treatment strategies in clinical practice. Funding 2035266 /api/funding/2035266 (RRF-2.3.1-21-2022-00003) false true Funding 2035267 /api/funding/2035267 (TKP2021-EGA-23) Funder: Ministry for Innovation and Technology false true true 2023 true true true false true false GOLD 2026-05-23 false http://www.mdpi.com/journal/ijms 15 0 15 15 0 15 15 14 6 15 15 15 15 15 0 0 15 15 15 15 0 9 9 Folyóiratcikk Journal Article 24 15 Könyvrészlet Chapter in Book 25 0 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2024 0 4 4 4 4 2025 0 5 5 5 5 2026 0 6 6 6 6 D1 false false false false 2024-01-07T12:43:17.141+0000 Kardiológia Központ - Kardiológiai Tanszék (SE / AOK / K); Repülõ- és Űrorvostani Tanszék (SE / AOK / K); Sportorvostan Tanszék (SE / AOK / K); Városmajori Szív- és Érgyógyászati Klinika (SE / AOK / K) 3 29 4 4 0 true Language 10002 /api/language/10002 English Angol English true 2 true PersonAuthorship 113424774 /api/authorship/113424774 Molnár, Andrea Ágnes ✉ [Molnár, Andrea Ágnes (kardiológia, belg...), author] Cardiovascular Center (SU / FM / C); Department of Cardiology – Heart and Vascular C... (SU / FM / C) 1 0.25 true false true Author 10015399 /api/author/10015399 Andrea Ágnes Molnár (kardiológia, belgyógyászat) Molnár Andrea Ágnes true 10015399 true Molnár Andrea Ágnes true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 113424775 /api/authorship/113424775 Pásztor, Dorottya Tímea [Pásztor, Dorottya Tímea (Szív- és Érgyógyá...), author] 2 0.25 false false false Author 10090017 /api/author/10090017 Dorottya Tímea Pásztor (Szív- és Érgyógyászat) Pásztor Dorottya Tímea true true Pásztor Dorottya Tímea true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 113424776 /api/authorship/113424776 Tarcza, Zsófia 3 0.25 false false false Tarcza Zsófia true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 113424777 /api/authorship/113424777 Merkely, Béla [Merkely, Béla Péter (Kardiológia), author] Cardiovascular Center (SU / FM / C); Department of Cardiology – Heart and Vascular C... (SU / FM / C); Faculty of Sports Medicine (SU / FM / C); Aerospace Medicine Department (SU / FM / C) 4 0.25 false true false Author 10002691 /api/author/10002691 Béla Péter Merkely (Kardiológia) Merkely Béla Péter true 10002691 true Merkely Béla true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PublicationIdentifier 25140826 /api/publicationidentifier/25140826 DOI: 10.3390/ijms242417129 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true IDENTICAL 10.3390/ijms242417129 https://doi.org/10.3390/ijms242417129 false true PublicationIdentifier 25279905 /api/publicationidentifier/25279905 WoS: 001130529000001 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 001130529000001 https://www.webofscience.com/wos/woscc/full-record/001130529000001 true true PublicationIdentifier 25246785 /api/publicationidentifier/25246785 Scopus: 85180693542 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85180693542 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85180693542 true true PublicationIdentifier 25246780 /api/publicationidentifier/25246780 PubMed: 38138958 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 38138958 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=38138958&dopt=Abstract true true SjrRating 11388415 /api/sjrrating/11388415 sjr:D1 (2023) Scopus - Inorganic Chemistry INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 7 0.1 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 1604 /api/classificationexternal/1604 Scopus - Inorganic Chemistry true 1604 true D1 DIRECT true true Reference 48251159 /api/reference/48251159 1. Townsend 2022: Epidemiology of cardiovascular disease in Europe., Nat. Rev. Cardiol., 19, p. 133, DOI: 10.1038/s41569-021-00607-3 1 10.1038/s41569-021-00607-3 false true Reference 48251160 /api/reference/48251160 2. Timmis 2022: European Society of Cardiology: Cardiovascular disease statistics 2021: Executive Summary., Eur. Heart J.-Qual. Care Clin. Outcomes, 8, p. 377, DOI: 10.1093/ehjqcco/qcac014 2 10.1093/ehjqcco/qcac014 false true Reference 48251161 /api/reference/48251161 3. Zhou 2022: Aging and Cardiovascular Disease: Current Status and Challenges., Rev. Cardiovasc. Med., 23, p. 135, DOI: 10.31083/j.rcm2304135 3 10.31083/j.rcm2304135 false true Reference 48251162 /api/reference/48251162 4. Roth 2020: Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study., J. Am. Coll. Cardiol., 76, p. 2982, DOI: 10.1016/j.jacc.2020.11.010 4 10.1016/j.jacc.2020.11.010 false true Reference 48251163 /api/reference/48251163 5. Libby 2019: Atherosclerosis., Nat. Rev. Dis. Primers, 5, p. 56, DOI: 10.1038/s41572-019-0106-z 5 10.1038/s41572-019-0106-z false true Reference 48251164 /api/reference/48251164 6. Wang 2012: Aging and atherosclerosis: Mechanisms, functional consequences, and potential therapeutics for cellular senescence., Circ. Res., 111, p. 245, DOI: 10.1161/CIRCRESAHA.111.261388 6 10.1161/CIRCRESAHA.111.261388 false true Reference 48251165 /api/reference/48251165 7. Blasco 2013: The hallmarks of aging., Cell, 153, p. 1194, DOI: 10.1016/j.cell.2013.05.039 7 10.1016/j.cell.2013.05.039 false true Reference 48251166 /api/reference/48251166 8. Hu 2022: Cellular Senescence in Cardiovascular Diseases: A Systematic Review., Aging Dis., 13, p. 103, DOI: 10.14336/AD.2021.0927 8 10.14336/AD.2021.0927 false true Reference 48251167 /api/reference/48251167 9. Bloom 2023: Mechanisms and consequences of endothelial cell senescence., Nat. Rev. Cardiol., 20, p. 38, DOI: 10.1038/s41569-022-00739-0 9 10.1038/s41569-022-00739-0 false true Reference 48251168 /api/reference/48251168 10. Engelen 2022: Therapeutic strategies targeting inflammation and immunity in atherosclerosis: How to proceed?., Nat. Rev. Cardiol., 19, p. 522, DOI: 10.1038/s41569-021-00668-4 10 10.1038/s41569-021-00668-4 false true Reference 48251169 /api/reference/48251169 11. Molnár, A., Pásztor, D., and Merkely, B. (2022). Cellular Senescence, Aging and Non-Aging Processes in Calcified Aortic Valve Stenosis: From Bench-Side to Bedside. Cells, 11., DOI: 10.3390/cells11213389 11 10.3390/cells11213389 false true Reference 48251170 /api/reference/48251170 12. Zhang 2021: Aging, Cell Senescence, the Pathogenesis and Targeted Therapies of Osteoarthritis., Front. Pharmacol., 12, p. 728100, DOI: 10.3389/fphar.2021.728100 12 10.3389/fphar.2021.728100 false true Reference 48251171 /api/reference/48251171 13. Guo 2022: Aging and aging-related diseases: From molecular mechanisms to interventions and treatments., Signal Transduct. Target. Ther., 7, p. 391, DOI: 10.1038/s41392-022-01251-0 13 10.1038/s41392-022-01251-0 false true Reference 48251172 /api/reference/48251172 14. Li 2019: Long-term stimulation of angiotensin II induced endothelial senescence and dysfunction., Exp. Gerontol., 119, p. 212, DOI: 10.1016/j.exger.2019.02.012 14 10.1016/j.exger.2019.02.012 false true Reference 48251173 /api/reference/48251173 15. Prattichizzo 2018: Short-term sustained hyperglycaemia fosters an archetypal senescence-associated secretory phenotype in endothelial cells and macrophages., Redox Biol., 15, p. 170, DOI: 10.1016/j.redox.2017.12.001 15 10.1016/j.redox.2017.12.001 false true Reference 48251174 /api/reference/48251174 16. Csiszar 2009: Anti-oxidative and anti-inflammatory vasoprotective effects of caloric restriction in aging: Role of circulating factors and SIRT1., Mech. Ageing Dev., 130, p. 518, DOI: 10.1016/j.mad.2009.06.004 16 10.1016/j.mad.2009.06.004 false true Reference 48251175 /api/reference/48251175 17. Zhang 2023: Targeting cellular senescence with senotherapeutics: Senolytics and senomorphics., FEBS J., 290, p. 1362, DOI: 10.1111/febs.16350 17 10.1111/febs.16350 false true Reference 48251176 /api/reference/48251176 18. Han 2023: Endothelial senescence in vascular diseases: Current understanding and future opportunities in senotherapeutics., Exp. Mol. Med., 55, p. 1, DOI: 10.1038/s12276-022-00906-w 18 10.1038/s12276-022-00906-w false true Reference 48251177 /api/reference/48251177 19. Suda, M., Paul, K.H., Minamino, T., Miller, J.D., Lerman, A., Ellison-Hughes, G.M., Tchkonia, T., and Kirkland, J.L. (2023). Senescent Cells: A Therapeutic Target in Cardiovascular Diseases. Cells, 12., DOI: 10.3390/cells12091296 19 10.3390/cells12091296 false true Reference 48251178 /api/reference/48251178 20. Yap 2021: Six Shades of Vascular Smooth Muscle Cells Illuminated by KLF4 (Krüppel-Like Factor 4)., Arterioscler. Thromb. Vasc. Biol., 41, p. 2693, DOI: 10.1161/ATVBAHA.121.316600 20 10.1161/ATVBAHA.121.316600 false true Reference 48251179 /api/reference/48251179 21. Rzucidlo 2007: Regulation of vascular smooth muscle cell differentiation., J. Vasc. Surg., 45, p. A25, DOI: 10.1016/j.jvs.2007.03.001 21 10.1016/j.jvs.2007.03.001 false true Reference 48251180 /api/reference/48251180 22. Cao 2022: How vascular smooth muscle cell phenotype switching contributes to vascular disease., Cell Commun. Signal, 20, p. 180, DOI: 10.1186/s12964-022-00993-2 22 10.1186/s12964-022-00993-2 false true Reference 48251181 /api/reference/48251181 23. Zhang 2021: An update on the phenotypic switching of vascular smooth muscle cells in the pathogenesis of atherosclerosis., Cell. Mol. Life Sci., 79, p. 6, DOI: 10.1007/s00018-021-04079-z 23 10.1007/s00018-021-04079-z false true Reference 48251182 /api/reference/48251182 24. Libby 2021: The changing landscape of atherosclerosis., Nature, 592, p. 524, DOI: 10.1038/s41586-021-03392-8 24 10.1038/s41586-021-03392-8 false true Reference 48251183 /api/reference/48251183 25. Noothi 2023: Residual risks and evolving atherosclerotic plaques., Mol. Cell Biochem., 478, p. 2629, DOI: 10.1007/s11010-023-04689-0 25 10.1007/s11010-023-04689-0 false true Reference 48251184 /api/reference/48251184 26. Bentzon 2014: Mechanisms of plaque formation and rupture., Circ. Res., 114, p. 1852, DOI: 10.1161/CIRCRESAHA.114.302721 26 10.1161/CIRCRESAHA.114.302721 false true Reference 48251185 /api/reference/48251185 27. Newman 2021: Multiple cell types contribute to the atherosclerotic lesion fibrous cap by PDGFRβ and bioenergetic mechanisms., Nat. Metab., 3, p. 166, DOI: 10.1038/s42255-020-00338-8 27 10.1038/s42255-020-00338-8 false true Reference 48251186 /api/reference/48251186 28. Lee, S.J., Lee, I.K., and Jeon, J.H. (2020). Vascular Calcification-New Insights Into Its Mechanism. Int. J. Mol. Sci., 21., DOI: 10.3390/ijms21082685 28 10.3390/ijms21082685 false true Reference 48251187 /api/reference/48251187 29. Roijers 2011: Microcalcifications in early intimal lesions of atherosclerotic human coronary arteries., Am. J. Pathol., 178, p. 2879, DOI: 10.1016/j.ajpath.2011.02.004 29 10.1016/j.ajpath.2011.02.004 false true Reference 48251188 /api/reference/48251188 30. Wang, L., and Tang, C. (2020). Targeting Platelet in Atherosclerosis Plaque Formation: Current Knowledge and Future Perspectives. Int. J. Mol. Sci., 21., DOI: 10.3390/ijms21249760 30 10.3390/ijms21249760 false true Reference 48251189 /api/reference/48251189 31. Minamino 2007: Vascular cell senescence: Contribution to atherosclerosis., Circ. Res., 100, p. 15, DOI: 10.1161/01.RES.0000256837.40544.4a 31 10.1161/01.RES.0000256837.40544.4a false true Reference 48251190 /api/reference/48251190 32. Warboys 2014: Disturbed flow promotes endothelial senescence via a p53-dependent pathway., Arterioscler. Thromb. Vasc. Biol., 34, p. 985, DOI: 10.1161/ATVBAHA.114.303415 32 10.1161/ATVBAHA.114.303415 false true Reference 48251191 /api/reference/48251191 33. McDonald 2018: Endothelial Regeneration of Large Vessels Is a Biphasic Process Driven by Local Cells with Distinct Proliferative Capacities., Cell Stem Cell, 23, p. 210, DOI: 10.1016/j.stem.2018.07.011 33 10.1016/j.stem.2018.07.011 false true Reference 48251192 /api/reference/48251192 34. Chang 1995: Telomere length and replicative aging in human vascular tissues., Proc. Natl. Acad. Sci. USA, 92, p. 11190, DOI: 10.1073/pnas.92.24.11190 34 10.1073/pnas.92.24.11190 false true Reference 48251193 /api/reference/48251193 35. McCarthy 2019: Novel Contributors and Mechanisms of Cellular Senescence in Hypertension-Associated Premature Vascular Aging., Am. J. Hypertens., 32, p. 709, DOI: 10.1093/ajh/hpz052 35 10.1093/ajh/hpz052 false true Reference 48251194 /api/reference/48251194 36. Durik 2020: Local endothelial DNA repair deficiency causes aging-resembling endothelial-specific dysfunction., Clin. Sci., 134, p. 727, DOI: 10.1042/CS20190124 36 10.1042/CS20190124 false true Reference 48251195 /api/reference/48251195 37. Liu 2020: Glucose-induced oxidative stress and accelerated aging in endothelial cells are mediated by the depletion of mitochondrial SIRTs., Physiol. Rep., 8, p. e14331, DOI: 10.14814/phy2.14331 37 10.14814/phy2.14331 false true Reference 48251196 /api/reference/48251196 38. Jiang 2020: Quercetin Attenuates Atherosclerosis via Modulating Oxidized LDL-Induced Endothelial Cellular Senescence., Front. Pharmacol., 11, p. 512, DOI: 10.3389/fphar.2020.00512 38 10.3389/fphar.2020.00512 false true Reference 48251197 /api/reference/48251197 39. Mortuza, R., Chen, S., Feng, B., Sen, S., and Chakrabarti, S. (2013). High glucose induced alteration of SIRTs in endothelial cells causes rapid aging in a p300 and FOXO regulated pathway. PLoS ONE, 8., DOI: 10.1371/journal.pone.0054514 39 10.1371/journal.pone.0054514 false true Reference 48251198 /api/reference/48251198 40. Yeung 2004: Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase., EMBO J., 23, p. 2369, DOI: 10.1038/sj.emboj.7600244 40 10.1038/sj.emboj.7600244 false true Reference 48251199 /api/reference/48251199 41. Ong 2018: Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming., Ageing Res. Rev., 43, p. 64, DOI: 10.1016/j.arr.2018.02.004 41 10.1016/j.arr.2018.02.004 false true Reference 48251200 /api/reference/48251200 42. Zhang 2008: Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice., Cardiovasc. Res., 80, p. 191, DOI: 10.1093/cvr/cvn224 42 10.1093/cvr/cvn224 false true Reference 48251201 /api/reference/48251201 43. Mattagajasingh 2007: SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase., Proc. Natl. Acad. Sci. USA, 104, p. 14855, DOI: 10.1073/pnas.0704329104 43 10.1073/pnas.0704329104 false true Reference 48251202 /api/reference/48251202 44. Csiszar 2008: Vasoprotective effects of resveratrol and SIRT1: Attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations., Am. J. Physiol. Heart Circ. Physiol., 294, p. H2721, DOI: 10.1152/ajpheart.00235.2008 44 10.1152/ajpheart.00235.2008 false true Reference 48251203 /api/reference/48251203 45. Chala 2021: Mechanical Fingerprint of Senescence in Endothelial Cells., Nano Lett., 21, p. 4911, DOI: 10.1021/acs.nanolett.1c00064 45 10.1021/acs.nanolett.1c00064 false true Reference 48251204 /api/reference/48251204 46. Tylutka, A., Morawin, B., Wawrzyniak-Gramacka, E., Wacka, E., Nowicka, W., Hiczkiewicz, J., and Zembron-Lacny, A. (2022). Immunosenescence in Aging-Related Vascular Dysfunction. Int. J. Mol. Sci., 23., DOI: 10.3390/ijms232113269 46 10.3390/ijms232113269 false true Reference 48251205 /api/reference/48251205 47. Hwang 2020: Endothelial cells under therapy-induced senescence secrete CXCL11, which increases aggressiveness of breast cancer cells., Cancer Lett., 490, p. 100, DOI: 10.1016/j.canlet.2020.06.019 47 10.1016/j.canlet.2020.06.019 false true Reference 48251206 /api/reference/48251206 48. Gole, S., Tkachenko, S., Masannat, T., Baylis, R.A., and Cherepanova, O.A. (2022). Endothelial-to-Mesenchymal Transition in Atherosclerosis: Friend or Foe?. Cells, 11., DOI: 10.3390/cells11192946 48 10.3390/cells11192946 false true Reference 48251207 /api/reference/48251207 49. Rodier 2009: Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion., Nat. Cell Biol., 11, p. 973, DOI: 10.1038/ncb1909 49 10.1038/ncb1909 false true Reference 48251208 /api/reference/48251208 50. Canugovi, C., Stevenson, M.D., Vendrov, A.E., Hayami, T., Robidoux, J., Xiao, H., Zhang, Y.Y., Eitzman, D.T., Runge, M.S., and Madamanchi, N.R. (2019). Increased mitochondrial NADPH oxidase 4 (NOX4) expression in aging is a causative factor in aortic stiffening. Redox Biol., 26., DOI: 10.1016/j.redox.2019.101288 50 10.1016/j.redox.2019.101288 false true Reference 48251209 /api/reference/48251209 51. Sanada 2017: Local Production of Activated Factor X in Atherosclerotic Plaque Induced Vascular Smooth Muscle Cell Senescence., Sci. Rep., 7, p. 17172, DOI: 10.1038/s41598-017-17508-6 51 10.1038/s41598-017-17508-6 false true Reference 48251210 /api/reference/48251210 52. Bennett 2016: Basic research: Killing the old: Cell senescence in atherosclerosis., Nat. Rev. Cardiol., 14, p. 8, DOI: 10.1038/nrcardio.2016.195 52 10.1038/nrcardio.2016.195 false true Reference 48251211 /api/reference/48251211 53. Tang 2010: Notch and transforming growth factor-beta (TGFbeta) signaling pathways cooperatively regulate vascular smooth muscle cell differentiation., J. Biol. Chem., 285, p. 17556, DOI: 10.1074/jbc.M109.076414 53 10.1074/jbc.M109.076414 false true Reference 48251212 /api/reference/48251212 54. Hartman 2021: Sex-Stratified Gene Regulatory Networks Reveal Female Key Driver Genes of Atherosclerosis Involved in Smooth Muscle Cell Phenotype Switching., Circulation, 143, p. 713, DOI: 10.1161/CIRCULATIONAHA.120.051231 54 10.1161/CIRCULATIONAHA.120.051231 false true Reference 48251213 /api/reference/48251213 55. Spin 2012: Vascular smooth muscle cell phenotypic plasticity: Focus on chromatin remodelling., Cardiovasc. Res., 95, p. 147, DOI: 10.1093/cvr/cvs098 55 10.1093/cvr/cvs098 false true Reference 48251214 /api/reference/48251214 56. Bruijn 2020: Extreme Diversity of the Human Vascular Mesenchymal Cell Landscape., J. Am. Heart Assoc., 9, p. e017094, DOI: 10.1161/JAHA.120.017094 56 10.1161/JAHA.120.017094 false true Reference 48251215 /api/reference/48251215 57. Hao 2006: Phenotypic Modulation of Intima and Media Smooth Muscle Cells in Fatal Cases of Coronary Artery Lesion., Arterioscler. Thromb. Vasc. Biol., 26, p. 326, DOI: 10.1161/01.ATV.0000199393.74656.4c 57 10.1161/01.ATV.0000199393.74656.4c false true Reference 48251216 /api/reference/48251216 58. Yang 2021: Role of Kruppel-like factor 4 in atherosclerosis., Clin. Chim. Acta, 512, p. 135, DOI: 10.1016/j.cca.2020.11.002 58 10.1016/j.cca.2020.11.002 false true Reference 48251217 /api/reference/48251217 59. Castiglioni 2017: ABCA1 and HDL(3) are required to modulate smooth muscle cells phenotypic switch after cholesterol loading., Atherosclerosis, 266, p. 8, DOI: 10.1016/j.atherosclerosis.2017.09.012 59 10.1016/j.atherosclerosis.2017.09.012 false true Reference 48251218 /api/reference/48251218 60. Vengrenyuk 2015: Cholesterol loading reprograms the microRNA-143/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype., Arterioscler. Thromb. Vasc. Biol., 35, p. 535, DOI: 10.1161/ATVBAHA.114.304029 60 10.1161/ATVBAHA.114.304029 false true Reference 48251219 /api/reference/48251219 61. Zhu 2019: Hyperhomocysteinemia induces vascular calcification by activating the transcription factor RUNX2 via Krüppel-like factor 4 up-regulation in mice., J. Biol. Chem., 294, p. 19465, DOI: 10.1074/jbc.RA119.009758 61 10.1074/jbc.RA119.009758 false true Reference 48251220 /api/reference/48251220 62. Tyson, J., Bundy, K., Roach, C., Douglas, H., Ventura, V., Segars, M.F., Schwartz, O., and Simpson, C.L. (2020). Mechanisms of the Osteogenic Switch of Smooth Muscle Cells in Vascular Calcification: WNT Signaling, BMPs, Mechanotransduction, and EndMT. Bioengineering, 7., DOI: 10.3390/bioengineering7030088 62 10.3390/bioengineering7030088 false true Reference 48251221 /api/reference/48251221 63. Liu 2018: Krüppel-like factor 10 (KLF10) is transactivated by the transcription factor C/EBPβ and involved in early 3T3-L1 preadipocyte differentiation., J. Biol. Chem., 293, p. 14012, DOI: 10.1074/jbc.RA118.004401 63 10.1074/jbc.RA118.004401 false true Reference 48251222 /api/reference/48251222 64. Covarrubias 2021: NAD(+) metabolism and its roles in cellular processes during ageing., Nat. Rev. Mol. Cell Biol., 22, p. 119, DOI: 10.1038/s41580-020-00313-x 64 10.1038/s41580-020-00313-x false true Reference 48251223 /api/reference/48251223 65. Vellasamy, D.M., Lee, S.J., Goh, K.W., Goh, B.H., Tang, Y.Q., Ming, L.C., and Yap, W.H. (2022). Targeting Immune Senescence in Atherosclerosis. Int. J. Mol. Sci., 23., DOI: 10.3390/ijms232113059 65 10.3390/ijms232113059 false true Reference 48251224 /api/reference/48251224 66. Vicente 2016: Cellular senescence impact on immune cell fate and function., Aging Cell, 15, p. 400, DOI: 10.1111/acel.12455 66 10.1111/acel.12455 false true Reference 48251225 /api/reference/48251225 67. Verschoor, C.P., Johnstone, J., Millar, J., Parsons, R., Lelic, A., Loeb, M., Bramson, J.L., and Bowdish, D.M. (2014). Alterations to the frequency and function of peripheral blood monocytes and associations with chronic disease in the advanced-age, frail elderly. PLoS ONE, 9., DOI: 10.1371/journal.pone.0104522 67 10.1371/journal.pone.0104522 false true Reference 48251226 /api/reference/48251226 68. Ong 2018: The pro-inflammatory phenotype of the human non-classical monocyte subset is attributed to senescence., Cell Death Dis., 9, p. 266, DOI: 10.1038/s41419-018-0327-1 68 10.1038/s41419-018-0327-1 false true Reference 48251227 /api/reference/48251227 69. Aiello 2019: Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention., Front. Immunol., 10, p. 2247, DOI: 10.3389/fimmu.2019.02247 69 10.3389/fimmu.2019.02247 false true Reference 48251228 /api/reference/48251228 70. Varasteh 2019: Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using (68)Ga-NOTA-anti-MMR nanobody: Non-invasive imaging of atherosclerotic plaques., EJNMMI Res., 9, p. 5, DOI: 10.1186/s13550-019-0474-0 70 10.1186/s13550-019-0474-0 false true Reference 48251229 /api/reference/48251229 71. Bobryshev, Y.V., Ivanova, E.A., Chistiakov, D.A., Nikiforov, N.G., and Orekhov, A.N. (2016). Macrophages and Their Role in Atherosclerosis: Pathophysiology and Transcriptome Analysis. Biomed. Res. Int., 2016., DOI: 10.1155/2016/9582430 71 10.1155/2016/9582430 false true Reference 48251230 /api/reference/48251230 72. Murray 2014: Macrophage activation and polarization: Nomenclature and experimental guidelines., Immunity, 41, p. 14, DOI: 10.1016/j.immuni.2014.06.008 72 10.1016/j.immuni.2014.06.008 false true Reference 48251231 /api/reference/48251231 73. Cochain 2018: Single-Cell RNA-Seq Reveals the Transcriptional Landscape and Heterogeneity of Aortic Macrophages in Murine Atherosclerosis., Circ. Res., 122, p. 1661, DOI: 10.1161/CIRCRESAHA.117.312509 73 10.1161/CIRCRESAHA.117.312509 false true Reference 48251232 /api/reference/48251232 74. Lin 2019: Single-cell analysis of fate-mapped macrophages reveals heterogeneity, including stem-like properties, during atherosclerosis progression and regression., JCI Insight, 4, p. e124574, DOI: 10.1172/jci.insight.124574 74 10.1172/jci.insight.124574 false true Reference 48251233 /api/reference/48251233 75. Cho 2020: CD9 induces cellular senescence and aggravates atherosclerotic plaque formation., Cell Death Differ., 27, p. 2681, DOI: 10.1038/s41418-020-0537-9 75 10.1038/s41418-020-0537-9 false true Reference 48251234 /api/reference/48251234 76. Fukuda 2019: Toll-Like Receptor 9 Plays a Pivotal Role in Angiotensin II-Induced Atherosclerosis., J. Am. Heart Assoc., 8, p. e010860, DOI: 10.1161/JAHA.118.010860 76 10.1161/JAHA.118.010860 false true Reference 48251235 /api/reference/48251235 77. Bellini 2022: Crosstalk between dendritic cells and T lymphocytes during atherogenesis: Focus on antigen presentation and break of tolerance., Front. Cardiovasc. Med., 9, p. 934314, DOI: 10.3389/fcvm.2022.934314 77 10.3389/fcvm.2022.934314 false true Reference 48251236 /api/reference/48251236 78. Guilliams 2016: Unsupervised High-Dimensional Analysis Aligns Dendritic Cells across Tissues and Species., Immunity, 45, p. 669, DOI: 10.1016/j.immuni.2016.08.015 78 10.1016/j.immuni.2016.08.015 false true Reference 48251237 /api/reference/48251237 79. Subramanian 2014: Dendritic cells in atherosclerosis., Semin. Immunopathol., 36, p. 93, DOI: 10.1007/s00281-013-0400-x 79 10.1007/s00281-013-0400-x false true Reference 48251238 /api/reference/48251238 80. Sichien 2017: Development of conventional dendritic cells: From common bone marrow progenitors to multiple subsets in peripheral tissues., Mucosal Immunol., 10, p. 831, DOI: 10.1038/mi.2017.8 80 10.1038/mi.2017.8 false true Reference 48251239 /api/reference/48251239 81. Manthey 2012: Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis., Circulation, 125, p. 1673, DOI: 10.1161/CIRCULATIONAHA.111.046755 81 10.1161/CIRCULATIONAHA.111.046755 false true Reference 48251240 /api/reference/48251240 82. Poznyak, A.V., Nikiforov, N.G., Starodubova, A.V., Popkova, T.V., and Orekhov, A.N. (2021). Macrophages and Foam Cells: Brief Overview of Their Role, Linkage, and Targeting Potential in Atherosclerosis. Biomedicines, 9., DOI: 10.3390/biomedicines9091221 82 10.3390/biomedicines9091221 false true Reference 48251241 /api/reference/48251241 83. Yilmaz 2004: Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques., Atherosclerosis, 176, p. 101, DOI: 10.1016/j.atherosclerosis.2004.04.027 83 10.1016/j.atherosclerosis.2004.04.027 false true Reference 48251242 /api/reference/48251242 84. Roy 2022: How the immune system shapes atherosclerosis: Roles of innate and adaptive immunity., Nat. Rev. Immunol., 22, p. 251, DOI: 10.1038/s41577-021-00584-1 84 10.1038/s41577-021-00584-1 false true Reference 48251243 /api/reference/48251243 85. Weber 2011: CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice., J. Clin. Investig., 121, p. 2898, DOI: 10.1172/JCI44925 85 10.1172/JCI44925 false true Reference 48251244 /api/reference/48251244 86. Choi 2011: Flt3 signaling-dependent dendritic cells protect against atherosclerosis., Immunity, 35, p. 819, DOI: 10.1016/j.immuni.2011.09.014 86 10.1016/j.immuni.2011.09.014 false true Reference 48251245 /api/reference/48251245 87. Boren 2004: Inflamm-aging: Autoimmunity, and the immune-risk phenotype., Autoimmun. Rev., 3, p. 401, DOI: 10.1016/j.autrev.2004.03.004 87 10.1016/j.autrev.2004.03.004 false true Reference 48251246 /api/reference/48251246 88. Agrawal 2009: Increased reactivity of dendritic cells from aged subjects to self-antigen, the human DNA., J. Immunol., 182, p. 1138, DOI: 10.4049/jimmunol.182.2.1138 88 10.4049/jimmunol.182.2.1138 false true Reference 48251247 /api/reference/48251247 89. Agrawal 2012: Dendritic cells and aging: Consequences for autoimmunity., Expert Rev. Clin. Immunol., 8, p. 73, DOI: 10.1586/eci.11.77 89 10.1586/eci.11.77 false true Reference 48251248 /api/reference/48251248 90. Warnatsch 2015: Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis., Science, 349, p. 316, DOI: 10.1126/science.aaa8064 90 10.1126/science.aaa8064 false true Reference 48251249 /api/reference/48251249 91. Braster 2019: Externalized histone H4 orchestrates chronic inflammation by inducing lytic cell death., Nature, 569, p. 236, DOI: 10.1038/s41586-019-1167-6 91 10.1038/s41586-019-1167-6 false true Reference 48251250 /api/reference/48251250 92. Klopf, J., Brostjan, C., Eilenberg, W., and Neumayer, C. (2021). Neutrophil Extracellular Traps and Their Implications in Cardiovascular and Inflammatory Disease. Int. J. Mol. Sci., 22., DOI: 10.3390/ijms22020559 92 10.3390/ijms22020559 false true Reference 48251251 /api/reference/48251251 93. Genkel 2022: Circulating Ageing Neutrophils as a Marker of Asymptomatic Polyvascular Atherosclerosis in Statin-Naïve Patients without Established Cardiovascular Disease., Int. J. Mol. Sci., 23, p. 10195, DOI: 10.3390/ijms231710195 93 10.3390/ijms231710195 false true Reference 48251252 /api/reference/48251252 94. Winkels 2021: Heterogeneity of T Cells in Atherosclerosis Defined by Single-Cell RNA-Sequencing and Cytometry by Time of Flight., Arterioscler. Thromb. Vasc. Biol., 41, p. 549, DOI: 10.1161/ATVBAHA.120.312137 94 10.1161/ATVBAHA.120.312137 false true Reference 48251253 /api/reference/48251253 95. Hinkley, H., Counts, D.A., VonCanon, E., and Lacy, M. (2023). T Cells in Atherosclerosis: Key Players in the Pathogenesis of Vascular Disease. Cells, 12., DOI: 10.3390/cells12172152 95 10.3390/cells12172152 false true Reference 48251254 /api/reference/48251254 96. Weinstock 2021: Wnt signaling enhances macrophage responses to IL-4 and promotes resolution of atherosclerosis., Elife, 10, p. e67932, DOI: 10.7554/eLife.67932 96 10.7554/eLife.67932 false true Reference 48251255 /api/reference/48251255 97. Davenport 2003: The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice., Am. J. Pathol., 163, p. 1117, DOI: 10.1016/S0002-9440(10)63471-2 97 10.1016/S0002-9440(10)63471-2 false true Reference 48251256 /api/reference/48251256 98. Pastrana 2012: Regulatory T cells and Atherosclerosis., J. Clin. Exp. Cardiolog, 2012, p. 2 98 false true Reference 48251257 /api/reference/48251257 99. Kritikou 2019: Disruption of a CD1d-mediated interaction between mast cells and NKT cells aggravates atherosclerosis., Atherosclerosis, 280, p. 132, DOI: 10.1016/j.atherosclerosis.2018.11.027 99 10.1016/j.atherosclerosis.2018.11.027 false true Reference 48251258 /api/reference/48251258 100. Mamoni 2013: Characterization of CD4+CD28null T cells in patients with coronary artery disease and individuals with risk factors for atherosclerosis., Cell Immunol., 281, p. 11, DOI: 10.1016/j.cellimm.2013.01.007 100 10.1016/j.cellimm.2013.01.007 false true Reference 48251259 /api/reference/48251259 101. Groenen 2021: Cholesterol efflux pathways, inflammation, and atherosclerosis., Crit. Rev. Biochem. Mol. Biol., 56, p. 426, DOI: 10.1080/10409238.2021.1925217 101 10.1080/10409238.2021.1925217 false true Reference 48251260 /api/reference/48251260 102. Larbi 2006: Differential role of lipid rafts in the functions of CD4+ and CD8+ human T lymphocytes with aging., Cell Signal, 18, p. 1017, DOI: 10.1016/j.cellsig.2005.08.016 102 10.1016/j.cellsig.2005.08.016 false true Reference 48251261 /api/reference/48251261 103. Bazioti 2023: T-cell Cholesterol Accumulation, Aging, and Atherosclerosis., Curr. Atheroscler. Rep., 25, p. 527, DOI: 10.1007/s11883-023-01125-y 103 10.1007/s11883-023-01125-y false true Reference 48251262 /api/reference/48251262 104. Jeng 2018: Metabolic reprogramming of human CD8(+) memory T cells through loss of SIRT1., J. Exp. Med., 215, p. 51, DOI: 10.1084/jem.20161066 104 10.1084/jem.20161066 false true Reference 48251263 /api/reference/48251263 105. Sage 2019: The role of B cells in atherosclerosis., Nat. Rev. Cardiol., 16, p. 180, DOI: 10.1038/s41569-018-0106-9 105 10.1038/s41569-018-0106-9 false true Reference 48251264 /api/reference/48251264 106. Frasca 2018: Senescent B cells in aging and age-related diseases: Their role in the regulation of antibody responses., Exp. Gerontol., 107, p. 55, DOI: 10.1016/j.exger.2017.07.002 106 10.1016/j.exger.2017.07.002 false true Reference 48251265 /api/reference/48251265 107. Pirillo 2013: LOX-1, OxLDL, and atherosclerosis., Mediators Inflamm., 2013, p. 152786, DOI: 10.1155/2013/152786 107 10.1155/2013/152786 false true Reference 48251266 /api/reference/48251266 108. Lu 2018: Impact of miRNA in Atherosclerosis., Arterioscler. Thromb. Vasc. Biol., 38, p. e159, DOI: 10.1161/ATVBAHA.118.310227 108 10.1161/ATVBAHA.118.310227 false true Reference 48251267 /api/reference/48251267 109. Bulati 2014: Trafficking phenotype and production of granzyme B by double negative B cells (IgG(+)IgD(-)CD27(-)) in the elderly., Exp. Gerontol., 54, p. 123, DOI: 10.1016/j.exger.2013.12.011 109 10.1016/j.exger.2013.12.011 false true Reference 48251268 /api/reference/48251268 110. Ruderman 2004: AMP kinase and malonyl-CoA: Targets for therapy of the metabolic syndrome., Nat. Rev. Drug Discov., 3, p. 340, DOI: 10.1038/nrd1344 110 10.1038/nrd1344 false true Reference 48251269 /api/reference/48251269 111. Bick 2020: Genetic Interleukin 6 Signaling Deficiency Attenuates Cardiovascular Risk in Clonal Hematopoiesis., Circulation, 141, p. 124, DOI: 10.1161/CIRCULATIONAHA.119.044362 111 10.1161/CIRCULATIONAHA.119.044362 false true Reference 48251270 /api/reference/48251270 112. Jaiswal 2017: Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease., N. Engl. J. Med., 377, p. 111, DOI: 10.1056/NEJMoa1701719 112 10.1056/NEJMoa1701719 false true Reference 48251271 /api/reference/48251271 113. Tyrrell 2021: Ageing and atherosclerosis: Vascular intrinsic and extrinsic factors and potential role of IL-6., Nat. Rev. Cardiol., 18, p. 58, DOI: 10.1038/s41569-020-0431-7 113 10.1038/s41569-020-0431-7 false true Reference 48251272 /api/reference/48251272 114. Wang 2018: Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2 (V617F) Mice., Circ. Res., 123, p. e35, DOI: 10.1161/CIRCRESAHA.118.313283 114 10.1161/CIRCRESAHA.118.313283 false true Reference 48251273 /api/reference/48251273 115. Heyde 2021: Increased stem cell proliferation in atherosclerosis accelerates clonal hematopoiesis., Cell, 184, p. 1348, DOI: 10.1016/j.cell.2021.01.049 115 10.1016/j.cell.2021.01.049 false true Reference 48251274 /api/reference/48251274 116. Jaiswal 2020: Clonal haematopoiesis: Connecting ageing and inflammation in cardiovascular disease., Nat. Rev. Cardiol., 17, p. 137, DOI: 10.1038/s41569-019-0247-5 116 10.1038/s41569-019-0247-5 false true Reference 48251275 /api/reference/48251275 117. Vega 2017: The atheroma plaque secretome stimulates the mobilization of endothelial progenitor cells ex vivo., J. Mol. Cell Cardiol., 105, p. 12, DOI: 10.1016/j.yjmcc.2017.02.001 117 10.1016/j.yjmcc.2017.02.001 false true Reference 48251276 /api/reference/48251276 118. Eslava-Alcon, S., Extremera-García, M.J., Sanchez-Gomar, I., Beltrán-Camacho, L., Rosal-Vela, A., Muñoz, J., Ibarz, N., Alonso-Piñero, J.A., Rojas-Torres, M., and Jiménez-Palomares, M. (2020). Atherosclerotic Pre-Conditioning Affects the Paracrine Role of Circulating Angiogenic Cells Ex-Vivo. Int. J. Mol. Sci., 21., DOI: 10.3390/ijms21155256 118 10.3390/ijms21155256 false true Reference 48251277 /api/reference/48251277 119. Altabas, V., and Biloš, L.S.K. (2022). The Role of Endothelial Progenitor Cells in Atherosclerosis and Impact of Anti-Lipemic Treatments on Endothelial Repair. Int. J. Mol. Sci., 23., DOI: 10.3390/ijms23052663 119 10.3390/ijms23052663 false true Reference 48251278 /api/reference/48251278 120. Yang 2018: Endothelial progenitor cells in age-related vascular remodeling., Cell Transplant., 27, p. 786, DOI: 10.1177/0963689718779345 120 10.1177/0963689718779345 false true Reference 48251279 /api/reference/48251279 121. Kumboyono 2021: Differences in senescence of late Endothelial Progenitor Cells in non-smokers and smokers., Tob. Induc. Dis., 19, p. 10, DOI: 10.18332/tid/135320 121 10.18332/tid/135320 false true Reference 48251280 /api/reference/48251280 122. Imanishi 2008: Endothelial progenitor cells dysfunction and senescence: Contribution to oxidative stress., Curr. Cardiol. Rev., 4, p. 275, DOI: 10.2174/157340308786349435 122 10.2174/157340308786349435 false true Reference 48251281 /api/reference/48251281 123. Williamson 2012: Endothelial progenitor cells enter the aging arena., Front. Physiol., 3, p. 30, DOI: 10.3389/fphys.2012.00030 123 10.3389/fphys.2012.00030 false true Reference 48251282 /api/reference/48251282 124. Dagher 2021: Design of a Randomized Placebo-Controlled Trial to Evaluate the Anti-inflammatory and Senolytic Effects of Quercetin in Patients Undergoing Coronary Artery Bypass Graft Surgery., Front. Cardiovasc. Med., 8, p. 741542, DOI: 10.3389/fcvm.2021.741542 124 10.3389/fcvm.2021.741542 false true Reference 48251283 /api/reference/48251283 125. Suda 2021: Senolytic vaccination improves normal and pathological age-related phenotypes and increases lifespan in progeroid mice., Nat. Aging, 1, p. 1117, DOI: 10.1038/s43587-021-00151-2 125 10.1038/s43587-021-00151-2 false true Reference 48251284 /api/reference/48251284 126. Mendelsohn 2022: Antiaging Vaccines Targeting Senescent Cells., Rejuvenation Res., 25, p. 39, DOI: 10.1089/rej.2022.0008 126 10.1089/rej.2022.0008 false true Reference 48251285 /api/reference/48251285 127. Amor 2020: Senolytic CAR T cells reverse senescence-associated pathologies., Nature, 583, p. 127, DOI: 10.1038/s41586-020-2403-9 127 10.1038/s41586-020-2403-9 false true Reference 48251286 /api/reference/48251286 128. 2012: Body fat distribution and risk of cardiovascular disease: An update., Circulation, 126, p. 1301, DOI: 10.1161/CIRCULATIONAHA.111.067264 128 10.1161/CIRCULATIONAHA.111.067264 false true Reference 48251287 /api/reference/48251287 129. Yoshida 2020: The CD153 vaccine is a senotherapeutic option for preventing the accumulation of senescent T cells in mice., Nat. Commun., 11, p. 2482, DOI: 10.1038/s41467-020-16347-w 129 10.1038/s41467-020-16347-w false true Reference 48251288 /api/reference/48251288 130. Laberge 2015: MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation., Nat. Cell Biol., 17, p. 1049, DOI: 10.1038/ncb3195 130 10.1038/ncb3195 false true Reference 48251289 /api/reference/48251289 131. Houssaini 2018: mTOR pathway activation drives lung cell senescence and emphysema., JCI Insight, 3, p. e93203, DOI: 10.1172/jci.insight.93203 131 10.1172/jci.insight.93203 false true Reference 48251290 /api/reference/48251290 132. Lesniewski 2017: Dietary rapamycin supplementation reverses age-related vascular dysfunction and oxidative stress, while modulating nutrient-sensing, cell cycle, and senescence pathways., Aging Cell, 16, p. 17, DOI: 10.1111/acel.12524 132 10.1111/acel.12524 false true Reference 48251291 /api/reference/48251291 133. Saito 2014: A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: The CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with Coronary Artery Disease) trial., Eur. Heart J., 35, p. 2021, DOI: 10.1093/eurheartj/ehu210 133 10.1093/eurheartj/ehu210 false true Reference 48251292 /api/reference/48251292 134. Chevalier 2020: Comparison of long-term clinical outcomes in multivessel coronary artery disease patients treated either with bioresoarbable polymer sirolimus-eluting stent or permanent polymer everolimus-eluting stent: 5-year results of the CENTURY II randomized clinical trial., Catheter. Cardiovasc. Interv., 95, p. 175, DOI: 10.1002/ccd.28224 134 10.1002/ccd.28224 false true Reference 48251293 /api/reference/48251293 135. Chisari, A., Pistritto, A.M., Piccolo, R., La Manna, A., and Danzi, G.B. (2016). The Ultimaster Biodegradable-Polymer Sirolimus-Eluting Stent: An Updated Review of Clinical Evidence. Int. J. Mol. Sci., 17., DOI: 10.3390/ijms17091490 135 10.3390/ijms17091490 false true Reference 48251294 /api/reference/48251294 136. Moiseeva 2013: Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-κB activation., Aging Cell, 12, p. 489, DOI: 10.1111/acel.12075 136 10.1111/acel.12075 false true Reference 48251295 /api/reference/48251295 137. Forouzandeh 2014: Metformin beyond diabetes: Pleiotropic benefits of metformin in attenuation of atherosclerosis., J. Am. Heart Assoc., 3, p. e001202, DOI: 10.1161/JAHA.114.001202 137 10.1161/JAHA.114.001202 false true Reference 48251296 /api/reference/48251296 138. Kurdi 2016: Potential therapeutic effects of mTOR inhibition in atherosclerosis., Br. J. Clin. Pharmacol., 82, p. 1267, DOI: 10.1111/bcp.12820 138 10.1111/bcp.12820 false true Reference 48251297 /api/reference/48251297 139. Scalera 2005: Aspirin reduces endothelial cell senescence., Biochem. Biophys. Res. Commun., 334, p. 1226, DOI: 10.1016/j.bbrc.2005.07.014 139 10.1016/j.bbrc.2005.07.014 false true Reference 48251298 /api/reference/48251298 140. Ota 2010: Induction of endothelial nitric oxide synthase, SIRT1, and catalase by statins inhibits endothelial senescence through the Akt pathway., Arterioscler. Thromb. Vasc. Biol., 30, p. 2205, DOI: 10.1161/ATVBAHA.110.210500 140 10.1161/ATVBAHA.110.210500 false true Reference 48251299 /api/reference/48251299 141. Herbert 2008: Angiotensin II-mediated oxidative DNA damage accelerates cellular senescence in cultured human vascular smooth muscle cells via telomere-dependent and independent pathways., Circ. Res., 102, p. 201, DOI: 10.1161/CIRCRESAHA.107.158626 141 10.1161/CIRCRESAHA.107.158626 false true Reference 48251300 /api/reference/48251300 142. Oeseburg 2009: Bradykinin protects against oxidative stress-induced endothelial cell senescence., Hypertension, 53, p. 417, DOI: 10.1161/HYPERTENSIONAHA.108.123729 142 10.1161/HYPERTENSIONAHA.108.123729 false true Reference 48251301 /api/reference/48251301 143. Visseren 2021: 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice., Eur. Heart J., 42, p. 3227, DOI: 10.1093/eurheartj/ehab484 143 10.1093/eurheartj/ehab484 false true Reference 48251302 /api/reference/48251302 144. Gal, R., Deres, L., Toth, K., Halmosi, R., and Habon, T. (2021). The Effect of Resveratrol on the Cardiovascular System from Molecular Mechanisms to Clinical Results. Int. J. Mol. Sci., 22., DOI: 10.3390/ijms221810152 144 10.3390/ijms221810152 false true Reference 48251303 /api/reference/48251303 145. Si 2014: Dietary antiaging phytochemicals and mechanisms associated with prolonged survival., J. Nutr. Biochem., 25, p. 581, DOI: 10.1016/j.jnutbio.2014.02.001 145 10.1016/j.jnutbio.2014.02.001 false true Reference 48251304 /api/reference/48251304 146. Zordoky 2015: Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases., Biochim. Biophys. Acta (BBA)-Mol. Basis Dis., 1852, p. 1155, DOI: 10.1016/j.bbadis.2014.10.016 146 10.1016/j.bbadis.2014.10.016 false true Reference 48251305 /api/reference/48251305 147. Xia 2017: Antioxidant effects of resveratrol in the cardiovascular system., Br. J. Pharmacol., 174, p. 1633, DOI: 10.1111/bph.13492 147 10.1111/bph.13492 false true Reference 48251306 /api/reference/48251306 148. Pyo, I.S., Yun, S., Yoon, Y.E., Choi, J.W., and Lee, S.J. (2020). Mechanisms of Aging and the Preventive Effects of Resveratrol on Age-Related Diseases. Molecules, 25., DOI: 10.3390/molecules25204649 148 10.3390/molecules25204649 false true Reference 48251307 /api/reference/48251307 149. Ungvari 2009: Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells., Am. J. Physiol. Heart Circ. Physiol., 297, p. H1876, DOI: 10.1152/ajpheart.00375.2009 149 10.1152/ajpheart.00375.2009 false true Reference 48251308 /api/reference/48251308 150. Ungvari 2010: Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2., Am. J. Physiol. Heart Circ. Physiol., 299, p. H18, DOI: 10.1152/ajpheart.00260.2010 150 10.1152/ajpheart.00260.2010 false true Reference 48251309 /api/reference/48251309 151. Ji 2022: Resveratrol protects against atherosclerosis by downregulating the PI3K/AKT/mTOR signaling pathway in atherosclerosis model mice., Exp. Ther. Med., 23, p. 414, DOI: 10.3892/etm.2022.11341 151 10.3892/etm.2022.11341 false true Reference 48251310 /api/reference/48251310 152. Seo 2019: Antiatherogenic Effect of Resveratrol Attributed to Decreased Expression of ICAM-1 (Intercellular Adhesion Molecule-1)., Arterioscler. Thromb. Vasc. Biol., 39, p. 675, DOI: 10.1161/ATVBAHA.118.312201 152 10.1161/ATVBAHA.118.312201 false true Reference 48251311 /api/reference/48251311 153. Thompson, A.M., Martin, K.A., and Rzucidlo, E.M. (2014). Resveratrol induces vascular smooth muscle cell differentiation through stimulation of SirT1 and AMPK. PLoS ONE, 9., DOI: 10.1371/journal.pone.0085495 153 10.1371/journal.pone.0085495 false true Reference 48251312 /api/reference/48251312 154. Singh 2019: Health benefits of resveratrol: Evidence from clinical studies., Med. Res. Rev., 39, p. 1851, DOI: 10.1002/med.21565 154 10.1002/med.21565 false true Reference 48251313 /api/reference/48251313 155. Agarwal 2013: Resveratrol for primary prevention of atherosclerosis: Clinical trial evidence for improved gene expression in vascular endothelium., Int. J. Cardiol., 166, p. 246, DOI: 10.1016/j.ijcard.2012.09.027 155 10.1016/j.ijcard.2012.09.027 false true Reference 48251314 /api/reference/48251314 156. Luo 2014: Nut consumption and risk of type 2 diabetes, cardiovascular disease, and all-cause mortality: A systematic review and meta-analysis., Am. J. Clin. Nutr., 100, p. 256, DOI: 10.3945/ajcn.113.076109 156 10.3945/ajcn.113.076109 false true Reference 48251315 /api/reference/48251315 157. Jiang 2006: Nut and seed consumption and inflammatory markers in the multi-ethnic study of atherosclerosis., Am. J. Epidemiol., 163, p. 222, DOI: 10.1093/aje/kwj033 157 10.1093/aje/kwj033 false true Reference 48251316 /api/reference/48251316 158. Ros 2011: Nuts, hypertension and endothelial function., Nutr. Metab. Cardiovasc. Dis., 21, p. S21, DOI: 10.1016/j.numecd.2011.01.009 158 10.1016/j.numecd.2011.01.009 false true Reference 48251317 /api/reference/48251317 159. Estruch 2018: Retraction and Republication: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet. N Engl J Med 2013;368:1279-90., N. Engl. J. Med., 378, p. 2441, DOI: 10.1056/NEJMc1806491 159 10.1056/NEJMc1806491 false true Reference 48251318 /api/reference/48251318 160. Vromman 2019: Stage-dependent differential effects of interleukin-1 isoforms on experimental atherosclerosis., Eur. Heart J., 40, p. 2482, DOI: 10.1093/eurheartj/ehz008 160 10.1093/eurheartj/ehz008 false true Reference 48251319 /api/reference/48251319 161. Kerensky 2016: A randomized phase II study of Xilonix, a targeted therapy against interleukin 1α, for the prevention of superficial femoral artery restenosis after percutaneous revascularization., J. Vasc. Surg., 63, p. 133, DOI: 10.1016/j.jvs.2015.08.069 161 10.1016/j.jvs.2015.08.069 false true Reference 48251320 /api/reference/48251320 162. Ridker 2017: Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease., N. Engl. J. Med., 377, p. 1119, DOI: 10.1056/NEJMoa1707914 162 10.1056/NEJMoa1707914 false true Reference 48251321 /api/reference/48251321 163. Morton 2015: The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: The MRC-ILA Heart Study., Eur. Heart J., 36, p. 377, DOI: 10.1093/eurheartj/ehu272 163 10.1093/eurheartj/ehu272 false true Reference 48251322 /api/reference/48251322 164. Abbate 2020: Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST-Segment-Elevation Myocardial Infarction., J. Am. Heart Assoc., 9, p. e014941, DOI: 10.1161/JAHA.119.014941 164 10.1161/JAHA.119.014941 false true Reference 48251323 /api/reference/48251323 165. Broch 2021: Randomized Trial of Interleukin-6 Receptor Inhibition in Patients with Acute ST-Segment Elevation Myocardial Infarction., J. Am. Coll. Cardiol., 77, p. 1845, DOI: 10.1016/j.jacc.2021.02.049 165 10.1016/j.jacc.2021.02.049 false true Reference 48251324 /api/reference/48251324 166. Kleveland 2016: Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: A double-blind, randomized, placebo-controlled phase 2 trial., Eur. Heart J., 37, p. 2406, DOI: 10.1093/eurheartj/ehw171 166 10.1093/eurheartj/ehw171 false true Reference 48251325 /api/reference/48251325 167. Hui 2017: The British Society for Rheumatology Guideline for the Management of Gout., Rheumatology, 56, p. e1, DOI: 10.1093/rheumatology/kex156 167 10.1093/rheumatology/kex156 false true Reference 48251326 /api/reference/48251326 168. Nidorf 2013: Low-dose colchicine for secondary prevention of cardiovascular disease., J. Am. Coll. Cardiol., 61, p. 404, DOI: 10.1016/j.jacc.2012.10.027 168 10.1016/j.jacc.2012.10.027 false true Reference 48251327 /api/reference/48251327 169. Nidorf 2020: Colchicine in Patients with Chronic Coronary Disease., N. Engl. J. Med., 383, p. 1838, DOI: 10.1056/NEJMoa2021372 169 10.1056/NEJMoa2021372 false true Reference 48251328 /api/reference/48251328 170. Tardif 2019: Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction., N. Engl. J. Med., 381, p. 2497, DOI: 10.1056/NEJMoa1912388 170 10.1056/NEJMoa1912388 false true Reference 48251329 /api/reference/48251329 171. Ulander 2021: Hydroxychloroquine reduces interleukin-6 levels after myocardial infarction: The randomized, double-blind, placebo-controlled OXI pilot trial., Int. J. Cardiol., 337, p. 21, DOI: 10.1016/j.ijcard.2021.04.062 171 10.1016/j.ijcard.2021.04.062 false true Reference 48251330 /api/reference/48251330 172. Tang 2020: Inhibition of JAK2 Suppresses Myelopoiesis and Atherosclerosis in Apoe(-/-) Mice., Cardiovasc. Drugs Ther., 34, p. 145, DOI: 10.1007/s10557-020-06943-9 172 10.1007/s10557-020-06943-9 false true Reference 48251331 /api/reference/48251331 173. Yang, X., Jia, J., Yu, Z., Duanmu, Z., He, H., Chen, S., and Qu, C. (2020). Inhibition of JAK2/STAT3/SOCS3 signaling attenuates atherosclerosis in rabbit. BMC Cardiovasc. Disord., 20., DOI: 10.1186/s12872-020-01391-7 173 10.1186/s12872-020-01391-7 false true Reference 48251332 /api/reference/48251332 174. Cipriani 2013: Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice., Circulation, 127, p. 2114, DOI: 10.1161/CIRCULATIONAHA.113.001278 174 10.1161/CIRCULATIONAHA.113.001278 false true Reference 48251333 /api/reference/48251333 175. Ridker 2019: Low-Dose Methotrexate for the Prevention of Atherosclerotic Events., N. Engl. J. Med., 380, p. 752, DOI: 10.1056/NEJMoa1809798 175 10.1056/NEJMoa1809798 false true Reference 48251334 /api/reference/48251334 176. Ryan 2011: Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: A meta-analysis of randomized controlled trials., JAMA, 306, p. 864 176 false true Reference 48251335 /api/reference/48251335 177. Grootaert 2021: SIRT6 Protects Smooth Muscle Cells From Senescence and Reduces Atherosclerosis., Circ. Res., 128, p. 474, DOI: 10.1161/CIRCRESAHA.120.318353 177 10.1161/CIRCRESAHA.120.318353 false true Reference 48251336 /api/reference/48251336 178. Childs 2021: Senescent cells suppress innate smooth muscle cell repair functions in atherosclerosis., Nat. Aging, 1, p. 698, DOI: 10.1038/s43587-021-00089-5 178 10.1038/s43587-021-00089-5 false true /api/publication/34450917 Molnár Andrea Ágnes et al. Cells in Atherosclerosis: Focus on Cellular Senescence from Basic Science to Clinical Practice. (2023) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 24 24<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10015399"><a href="/gui2/?type=authors&mode=browse&sel=10015399" target="_blank">Molnár Andrea Ágnes ✉ (<span class="authorship-author-name">Molnár Andrea Ágnes</span> <span class="authorAux-mtmt"> kardiológia, belgyógyászat</span>) </a> </span> <span class="author-affil"><span title="Semmelweis University">SU</span>/<span title="Faculty of Medicine">FM</span>/<span title="Clinical">C</span>/Cardiovascular Center; <span title="Semmelweis University">SU</span>/<span title="Faculty of Medicine">FM</span>/<span title="Clinical">C</span>/<span title="Cardiovascular Center">Cardiovascular Center</span>/Department of Cardiology – Heart and Vascular Center</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10090017"><a href="/gui2/?type=authors&mode=browse&sel=10090017" target="_blank">Pásztor Dorottya Tímea (<span class="authorship-author-name">Pásztor Dorottya Tímea</span> <span class="authorAux-mtmt"> Szív- és Érgyógyászat</span>) </a> </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Tarcza Zsófia </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10002691"><a href="/gui2/?type=authors&mode=browse&sel=10002691" target="_blank">Merkely Béla (<span class="authorship-author-name">Merkely Béla Péter</span> <span class="authorAux-mtmt"> Kardiológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis University">SU</span>/<span title="Faculty of Medicine">FM</span>/<span title="Clinical">C</span>/Cardiovascular Center; <span title="Semmelweis University">SU</span>/<span title="Faculty of Medicine">FM</span>/<span title="Clinical">C</span>/<span title="Cardiovascular Center">Cardiovascular Center</span>/Department of Cardiology – Heart and Vascular Center; <span title="Semmelweis University">SU</span>/<span title="Faculty of Medicine">FM</span>/<span title="Clinical">C</span>/<span title="Cardiovascular Center">Cardiovascular Center</span>/Faculty of Sports Medicine; <span title="Semmelweis University">SU</span>/<span title="Faculty of Medicine">FM</span>/<span title="Clinical">C</span>/<span title="Cardiovascular Center">Cardiovascular Center</span>/Aerospace Medicine Department</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;34450917" target="_blank">Cells in Atherosclerosis: Focus on Cellular Senescence from Basic Science to Clinical Practice</a></div> <div> <span class="journal-title">INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/1661-6596">1661-6596</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1422-0067">1422-0067</a>)</span>: <span class="journal-volume">24</span> <span class="journal-issue">24</span> <span class="page"> Paper 17129. 23 p. </span> <span class="year">(2023)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Language: English | </span> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="10.3390/ijms242417129" target="_blank" href="https://doi.org/10.3390/ijms242417129"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="001130529000001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001130529000001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85180693542" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85180693542"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="38138958" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=38138958&dopt=Abstract"> PubMed </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Journal subject: Scopus - Inorganic Chemistry&nbsp;&nbsp;&nbsp;Rank:&nbsp;D1</div> <div class="journal-subject">Journal subject: Scopus - Organic Chemistry&nbsp;&nbsp;&nbsp;Rank:&nbsp;D1</div> <div class="journal-subject">Journal subject: Scopus - Spectroscopy&nbsp;&nbsp;&nbsp;Rank:&nbsp;D1</div> <div class="journal-subject">Journal subject: Scopus - Computer Science Applications&nbsp;&nbsp;&nbsp;Rank:&nbsp;Q1</div> <div class="journal-subject">Journal subject: Scopus - Medicine (miscellaneous)&nbsp;&nbsp;&nbsp;Rank:&nbsp;Q1</div> <div class="journal-subject">Journal subject: Scopus - Physical and Theoretical Chemistry&nbsp;&nbsp;&nbsp;Rank:&nbsp;Q1</div> <div class="journal-subject">Journal subject: Scopus - Catalysis&nbsp;&nbsp;&nbsp;Rank:&nbsp;Q2</div> <div class="journal-subject">Journal subject: Scopus - Molecular Biology&nbsp;&nbsp;&nbsp;Rank:&nbsp;Q2</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="" class="citingPub-count">Citing papers: 15</span> | Independent citation: 15 | Self citation: 0 | Unknown citation: 0 | Number of citations in WoS: 14 | Number of citations in Scopus:&nbsp;6 | WoS/Scopus assigned:&nbsp;15 | Number of citations with DOI:&nbsp;15 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;34450917&sort=publishedYear,desc&sort=title"> Number of cited publications: 9 </a> </div> <div class="mtid"><span class="long-pub-mtid">Publication: 34450917</span> | <span class="status-data status-VALIDATED"> Validated </span> Core Citing | <span class="type-subtype">Journal Article ( Survey paper ) </span> | <span class="pub-category">Scientific</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="funder"> (RRF-2.3.1-21-2022-00003), (TKP2021-EGA-23) Funder: Ministry for Innovation and Technology </div> <div class="lastModified">Last Modified: 2024.01.12. 08:36 Ágnes Szalóky-Siki (SE_KK_Admin5_SZSA, admin) </div> <pre class="comment" style="margin-top: 0; margin-bottom: 0;"><u>Comments</u>: Export Date: 20 March 2024 Correspondence Address: Molnár, A.Á.; Heart and Vascular Center, Hungary; email: molnarandreaagnes@gmail.com</pre> </div></div>